2026
Journal - Research Article
Hughes, R. C. E., Abraham, E., Chan, H., & Williman, J. A. (2026). Rapid postpartum progression to diabetes following early antenatal prediabetes: Evidence from a multiethnic New Zealand cohort. Diabetes Care, 49(3), dc252200. doi: 10.2337/dc25-2200
Conference Contribution - Published proceedings: Abstract
Hughes, R., & Lee, G. (2026). Diabetes in pregnancy: Routine screening for placental insufficiency using the sFlt/PlGF (DIPPS): Evidence to patent care. Proceedings of the New Zealand Society for the Study of Diabetes (NZSSD) Annual Scientific Meeting. (pp. 38). Retrieved from https://www.nzssd.org.nz/
2025
Journal - Research Article
Hughes, R. C. E., Kyle, P., Phillips, I., Florkowski, C. M., & Gullam, J. (2025). In suspected fetal growth restriction, sFlt-1/PlGF and PlGF may have value in risk stratification for preterm birth and birthweight < 3rd centile: A blinded cohort study. Australian & New Zealand Journal of Obstetrics & Gynaecology. Advance online publication. doi: 10.1111/ajo.70003
Conference Contribution - Published proceedings: Abstract
Hughes, R., MacKay, D., Gullam, J., & Florkowski, C. (2025). DIPPS stidu: Diabetes in pregnancy: Routine screening for placental insufficiency using the sFlt-1/PlGF. New Zealand Medical Journal/Te ara tika o te hauora hapori, 138(1619), (pp. 90). Retrieved from https://nzmj.org.nz/
Conference Contribution - Verbal presentation and other Conference outputs
Hughes, R. (2025, June). How can we utilise angiogenic biomarker testing (sFlt-1/PIGF) to improve care for mothers with hypertension in pregnancy? Verbal presentation at the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG) Aotearoa Annual Scientific Meeting, Dunedin, New Zealand.
2024
Journal - Research Other
Hall, R. M., Hughes, R. C. E., Lewis-Hills, E., & Rowan, J. A. (2024). Management of early dysglycaemia in pregnancy varies by region in Aotearoa New Zealand with risks of widening inequities. New Zealand Medical Journal/Te ara tika o te hauora hapori, 137(1595), 105-109. Retrieved from https://www.nzmj.org.nz/
Conference Contribution - Published proceedings: Abstract
Hughes, R., Phillips, I., Florkowski, C. M., & Gullam, J. (2024). Could the sflt-1/PLGF ratio have added value in the detection and management of small for gestational age and fetal growth restriction? A prospective blinded observational study. Journal of Paediatrics & Child Health, 60(Suppl. 1), (pp. 41). doi: 10.1111/jpc.16526
2023
Journal - Research Article
Hughes, R. C. E., Phillips, I., Florkowski, C. M., & Gullam, J. (2023). The predictive value of the sFlt-1/PlGF ratio in suspected preeclampsia in a New Zealand population: A prospective cohort study. Australian & New Zealand Journal of Obstetrics & Gynaecology, 63, 34-41. doi: 10.1111/ajo.13549
Journal - Research Other
de Carvalho Duarte, G., Farnden, L., Hughes, R. C. E., & Chan, H. (2023). Pregnancy-induced severe hypertriglyceridemia effectively treated with therapeutic plasmapheresis. Transfusion & Apheresis Science, 62, 103659. doi: 10.1016/j.transci.2023.103659
2022
Journal - Research Article
Crowther, C. A., Samuel, D., Hughes, R., Tran, T., Brown, J., Alsweiler, J. M., on behalf of the TARGET Study Group. (2022). Tighter or less tight glycaemic targets for women with gestational diabetes mellitus for reducing maternal and perinatal morbidity: A stepped-wedge, cluster-randomised trial. PLoS Medicine, 19(9), e1004087. doi: 10.1371/journal.pmed.1004087
Conference Contribution - Published proceedings: Abstract
Hughes, R., Phillips, I., Florkowski, C., & Gullam, J. (2022). Diabetes in pregnancy: Using the Sflt-1/PLGF ratio to predict preeclampsia. Proceedings of the 45th New Zealand Society for the Study of Diabetes (NZSSD) Annual Scientific Meeting. (pp. 18). Retrieved from https://www.ivvy.com.au/event/NZSSD22/welcome.html
2020
Journal - Research Article
Sina, M., Cade, T. J., Flack, J., Nolan, C. J., Rajagopal, R., Wong, V., … Hughes, R., … Simmons, D. (2020). Antenatal models of care for women with gestational diabetes mellitus: Vignettes from an international meeting. Australian & New Zealand Journal of Obstetrics & Gynaecology, 60, 720-728. doi: 10.1111/ajo.13144
Journal - Research Other
Rudland, V. L., Price, S. A. L., Hughes, R., Barrett, H. L., Lagstrom, J., Porter, C., … Callaway, L. (2020). ADIPS 2020 guideline for pre-existing diabetes and pregnancy. Australian & New Zealand Journal of Obstetrics & Gynaecology, 60, E18-E52. doi: 10.1111/ajo.13265
2019
Conference Contribution - Published proceedings: Abstract
Crowther, C. A., Hughes, R., Brown, J., Tran, T., Alsweiler, J., for the TARGET study group. (2019). Tight or less tight glycaemic targets for women with gestational diabetes mellitus for reducing maternal and perinatal morbidity? The TARGET trial. Journal of Paediatrics & Child Health, 55(Suppl. 1), (pp. 15). doi: 10.1111/jpc.14406
2018
Journal - Research Article
Hughes, R. C. E., Rowan, J., & Williman, J. (2018). Prediabetes in pregnancy, can early intervention improve outcomes? A feasibility study for a parallel randomised clinical trial. BMJ Open, 8(3), e018493. doi: 10.1136/bmjopen-2017-018493
Hughes, R. C. E., Florkowski, C., & Gullam, J. E. (2018). Evaluation of the NZ guidelines for screening for persistent postpartum hyperglycaemia following gestational diabetes. Australian & New Zealand Journal of Obstetrics & Gynaecology, 58(4), 432-437. doi: 10.1111/ajo.12746
Hughes, R. C. E., Williman, J. A., & Gullam, J. E. (2018). Antenatal haemoglobin A1c centiles: Does one size fit all? Australian & New Zealand Journal of Obstetrics & Gynaecology, 58(4), 411-416. doi: 10.1111/ajo.12738
Journal - Research Other
Crowther, C. A., Alsweiler, J. M., Hughes, R., Brown, J., and for the Target Study Group. (2018). Tight or less tight glycaemic targets for women with gestational diabetes mellitus for reducing maternal and perinatal morbidity? (TARGET): Study protocol for a stepped wedge randomised trial. BMC Pregnancy & Childbirth, 18, 425. doi: 10.1186/s12884-018-2060-2
2017
Journal - Research Other
Carey, R. J., Churcher, M., Hughes, R., Florkowski, C. M., Frampton, C. M., Heenan, H. F., & Lunt, H. (2017). Will the use of lyophilized citrate tubes lead to the over-diagnosis of diabetes in pregnancy? Journal of Applied Laboratory Medicine, 1(5), 592-594. doi: 10.1373/jalm.2016.022103
Conference Contribution - Poster Presentation (not in published proceedings)
Hughes, R., Gullam, J., Florkowski, C., & Yi, M. (2017, May). Evaluation of the latest NZ guidelines for screening for persistent postpartum hyperglycaemia following gestational diabetes. Poster session presented at the New Zealand Society for the Study of Diabetes (NZSSD) Annual Scientific Meeting, Dunedin, New Zealand.
Hughes, R., Rowan, J., & Williman, J. (2017, May). PINTO: Pre-diabetes in pregnancy, can early intervention improve outcomes? Results from the feasability study. Poster session presented at the New Zealand Society for the Study of Diabetes (NZSSD) Annual Scientific Meeting, Dunedin, New Zealand.
2016
Journal - Research Article
Hughes, R. C. E., Williman, J., & Gullam, J. E. (2016). Universal HbA1c measurement in early pregnancy to detect type 2 diabetes reduces ethnic disparities in antenatal diabetes screening: A population-based observational study. PLoS ONE, 11(6), e0156926. doi: 10.1371/journal.pone.0156926
Hughes, R. C. E., Rowan, J., & Florkowski, C. M. (2016). Is there a role for HbA1c in pregnancy? Current Diabetes Reports, 16(1), 5. doi: 10.1007/s11892-015-0698-y
Rowan, J. A., Budden, A., Ivanova, V., Hughes, R. C., & Sadler, L. C. (2016). Women with an HbA1c of 41-49 mmol/mol (5.9-6.6%): A higher risk subgroup that may benefit from early pregnancy intervention. Diabetic Medicine, 33(1), 25-31. doi: 10.1111/dme.12812
Conference Contribution - Poster Presentation (not in published proceedings)
Gullam, J. E., Williman, J., & Hughes, R. C. E. (2016, September). HBA1C reference range in pregnanacy: Are observed ethnic differences simply a reflection of blood glucose control? Poster session presented at the 10th Athens Congress on Women's Health and Disease: Preconceptions to Menopause, Athens, Greece.
Conference Contribution - Verbal presentation and other Conference outputs
Carey, R., Churcher, M., Heenan, H., Hughes, R., Florkowski, C., & Lunt, H. (2016, May). Measurement of pregnancy OGTT plasma glucose: Do citrate blood collection tubes lead to an over-diagnosis of GDM? Verbal presentation at the New Zealand Society for the Study of Diabetes (NZSSD) Annual Scientific Meeting, Rotorua, New Zealand.
Hughes, R. C. E., Williman, J., & Gullam, J. (2016, May). HbA1c reference-range in pregnancy: Observed ethnic differences may simply reflect blood glucose levels. Verbal presentation at the New Zealand Society for the Study of Diabetes (NZSSD) Annual Scientific Meeting, Rotorua, New Zealand.
2015
Journal - Research Other
Hughes, R. C. E., Moore, M. P., Gullam, J. E., & Rowan, J. (2015). [Response to comment on Hughes et al]. Diabetes Care, 38(6), e93. doi: 10.2337/dc15-0401
Rowan, J., Allen, H., Budden, A., Elder, R., Farrant, M., Hughes, R., … McGrath, N. (2015). New Zealand National GDM Guidelines: An alternative view of some good practice points. Australian & New Zealand Journal of Obstetrics & Gynaecology, 55(1), 17-20. doi: 10.1111/ajo.12302
2014
Journal - Research Article
Hughes, R. C. E., Moore, M. P., Gullam, J. E., Mohamed, K., & Rowan, J. (2014). An early pregnancy HbA1c ≥5.9% (41 mmol/mol) is optimal for detecting diabetes and identifies women at increased risk of adverse pregnancy outcomes. Diabetes Care, 37(11), 2953-2959. doi: 10.2337/dc14-1312
Conference Contribution - Verbal presentation and other Conference outputs
Hughes, R., Gullam, J., Rowan, J., & Moore, M. P. (2014, July). An HbA1c of 41-46 mmol/mol (5.0-6.4%) at booking is associated with an increased risk of adverse pregnancy outcomes. Verbal presentation at the Australasian Diabetes in Pregnancy Society and Society of Obstetric Medicine of Australia and New Zealand (ADIPS - SOMANZ) Joint Scientific Meeting, Queenstown, New Zealand.
Hughes, R. (2014, October). HbA1c at booking to screen for pre-gestational hyperglycaemia. Verbal presentation at the Perinatal Society of New Zealand (PSNZ) 34th Annual Scientific Meeting, Wellington, New Zealand.
2013
Conference Contribution - Verbal presentation and other Conference outputs
Hughes, R., Moore, P., Gullam, J., & Rowan, J. (2013, May). STEP: Screening for Type 2 diabetes in Early Pregnancy. Verbal presentation at the New Zealand Society for the Study of Diabetes (NZSSD) Annual Scientific Meeting, Napier, New Zealand.
Hughes, R., Moore, M. P., Gullam, J., & Rowan, J. (2013, October). First trimester HbA1c measurements to detect overt diabetes at booking: A prospective cohort study. Verbal presentation at the Diabetic Pregnancy Study Group (DPSG) 45th Annual Meeting, St Julians, Malta.
2012
Conference Contribution - Verbal presentation and other Conference outputs
Hughes, R., Moore, P., & Gullam, J. (2012, August-September). STEP: Screening for Type 2 diabetes in Early Pregnancy. Verbal presentation at the Australasian Diabetes in Pregnancy Society (ADIPS) Annual Scientific Meeting, Gold Coast, Australia.
Hughes, R., Gullam, J., & Moore, P. (2012, October). STEP: Screening for Type 2 diabetes in Early Pregnancy. Verbal presentation at the Society of Obstetric Medicine of Australia and New Zealand (SOMANZ) Annual Scientific Meeting, Sydney, Australia.
2010
Journal - Research Article
Rodwell, J., Fletcher, V., & Hughes, R. (2010). How well is cognitive function documented by medical staff in the over-65 age group at the time of acute medical admission? New Zealand Medical Journal, 123(1317). Retrieved from http://journal.nzma.org.nz/journal/123-1317/4182/content.pdf
2009
Journal - Research Article
Rowan, J. A., Luen, S., Hughes, R. C., Sadler, L. C., & McCowan, L. M. E. (2009). Customised birthweight centiles are useful for identifying small-for-gestational-age babies in women with type 2 diabetes. Australian & New Zealand Journal of Obstetrics & Gynaecology, 49(2), 180-184. doi: 10.1111/j.1479-828X.2009.00975.x
2006
Journal - Research Article
Hughes, R. C. E., & Rowan, J. A. (2006). Pregnancy in women with Type 2 diabetes: Who takes metformin and what is the outcome? Diabetic Medicine, 23(3), 318-322. doi: 10.1111/j.1464-5491.2006.01750.x
Hughes, R., & Rowan, J. (2006). Perinatal outcomes and macrosomia in a multi-ethnic population of women with type 2 diabetes. Australian & New Zealand Journal of Obstetrics & Gynaecology, 46(6), 552-555. doi: 10.1111/j.1479-828X.2006.00659.x
Hughes, R. C., Gardiner, S. J., Begg, E. J., & Zhang, M. (2006). Effect of pregnancy on the pharmacokinetics of metformin. Diabetic Medicine, 23(3), 323-326. doi: 10.1111/j.1464-5491.2005.01769.x
2005
Journal - Research Article
Gardiner, S. J., Begg, E. J., Zhang, M., & Hughes, R. C. (2005). Transfer of rofecoxib into human milk. European Journal of Clinical Pharmacology, 61(5-6), 405-408.